Register entryShortage reported
- Registered sites
- 6
- Active NDC listings
- 561
- Labeller names
- 8
- Live patents
- 73
- Shortage listings
- 185
- Countries
- 2
- Base
- United States
Authorisation
Registered operations
Analytical testing6Active ingredient (API) manufacture2Finished drug manufacture4
Sites
Registered establishments
6| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Fresenius Kabi AB | Kraftvagen 1, Kungsangen, Sweden 19637, Sweden (SWE) | Analytical testing, Active ingredient (API) manufacture | 3002996654632471082 |
| Fresenius Kabi AB | Rapsgatan 7, Uppsala, Sweden 75174, Sweden (SWE) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3002631703559785113 |
| Fresenius Kabi USA, LLC | 3159 Staley Road, Grand Island, New York (NY) 14072, United States (USA) | Analytical testing, Finished drug manufacture | 3001833549840771732 |
| Fresenius Kabi USA, LLC | 2045 N. Cornell Avenue, Melrose Park, Illinois (IL) 60160, United States (USA) | Analytical testing | 1000115163784336252 |
| Fresenius Kabi USA, LLC | 2085 North Hawthorne Avenue, Melrose Park, Illinois (IL) 60160, United States (USA) | Analytical testing, Finished drug manufacture | 1450022023648251 |
| Fresenius Kabi USA, LLC | 5200 Corporate Parkway West, Wilson, North Carolina (NC) 27893, United States (USA) | Analytical testing, Finished drug manufacture | 3008887707964475045 |
Alert
Drug shortage listings
185| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Azacitidine InjectionOncology | Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39) | Current | Unavailable | 18 Dec 202015 Sept 2026 |
| Bupivacaine Hydrochloride InjectionAnesthesia | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-31) | Current | Unavailable | 20 Feb 201815 Sept 2026 |
| Bupivacaine Hydrochloride InjectionAnesthesia | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-37) | Current | Available | 20 Feb 201815 Sept 2026 |
| Bupivacaine Hydrochloride InjectionAnesthesia | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-37) | Current | Available | 20 Feb 201815 Sept 2026 |
| Bupivacaine Hydrochloride InjectionAnesthesia | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-467-57) | Current | Available | 20 Feb 201815 Sept 2026 |
| Bupivacaine Hydrochloride InjectionAnesthesia | Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-17) | Current | Available | 20 Feb 201815 Sept 2026 |
| Bupivacaine Hydrochloride InjectionAnesthesia | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-17) | Current | Available | 20 Feb 201815 Sept 2026 |
| Bupivacaine Hydrochloride InjectionAnesthesia | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31) | Current | Unavailable | 20 Feb 201815 Sept 2026 |
| Bupivacaine Hydrochloride InjectionAnesthesia | Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-17) | Current | Available | 20 Feb 201815 Sept 2026 |
| Bupivacaine Hydrochloride InjectionAnesthesia | Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-465-57) | Current | Available | 20 Feb 201815 Sept 2026 |
| Bupivacaine Hydrochloride InjectionAnesthesia | Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-37) | Current | Available | 20 Feb 201815 Sept 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionAnesthesia | Sensorcaine, Injection, 7.5 mg/1 mL; .005 mg/1 mL (NDC 63323-460-37) | Current | Available | 20 Feb 201815 Sept 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionAnesthesia | Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-31) | Current | Unavailable | 20 Feb 201815 Sept 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionAnesthesia | Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-37) | Current | Available | 20 Feb 201815 Sept 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionAnesthesia | Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-17) | Current | Available | 20 Feb 201815 Sept 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionAnesthesia | Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-463-57) | Current | Available | 20 Feb 201815 Sept 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionAnesthesia | Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-461-57) | Current | Available | 20 Feb 201815 Sept 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionAnesthesia | Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-17) | Current | Available | 20 Feb 201815 Sept 2026 |
| Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionAnesthesia | Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-37) | Current | Available | 20 Feb 201815 Sept 2026 |
| Carboplatin InjectionOncology | Carboplatin, Injection, 10 mg/1 mL (NDC 63323-172-60) | Current | Unavailable | 28 Apr 202315 Sept 2026 |
| Dexamethasone Sodium Phosphate InjectionDermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01) | Current | Available | 8 Feb 201915 Sept 2026 |
| Dexamethasone Sodium Phosphate InjectionDermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10) | Current | Available | 8 Feb 201915 Sept 2026 |
| Dexamethasone Sodium Phosphate InjectionDermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30) | Current | Available | 8 Feb 201915 Sept 2026 |
| Dexamethasone Sodium Phosphate InjectionDermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-0210-10) | Current | Available | 8 Feb 201915 Sept 2026 |
| Dexamethasone Sodium Phosphate InjectionDermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10) | Current | Limited Availability | 8 Feb 201915 Sept 2026 |
| Dexamethasone Sodium Phosphate InjectionDermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05) | Current | Available | 8 Feb 201915 Sept 2026 |
| Dexamethasone Sodium Phosphate InjectionDermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology | Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10) | Current | Available | 8 Feb 201915 Sept 2026 |
| Dexamethasone Sodium Phosphate InjectionDermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology | Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10) | Current | Limited Availability | 8 Feb 201915 Sept 2026 |
| Dexamethasone Sodium Phosphate InjectionDermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology | Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01) | Current | Available | 8 Feb 201915 Sept 2026 |
| Dexmedetomidine Hydrochloride InjectionAnesthesia | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-20) | Current | Unavailable | 10 Apr 202015 Sept 2026 |
| Dexmedetomidine Hydrochloride InjectionAnesthesia | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-50) | Current | Unavailable | 10 Apr 202015 Sept 2026 |
| Dexmedetomidine Hydrochloride InjectionAnesthesia | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-00) | Current | Unavailable | 10 Apr 202015 Sept 2026 |
| Dexmedetomidine Hydrochloride InjectionAnesthesia | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 63323-421-02) | Current | Unavailable | 10 Apr 202015 Sept 2026 |
| Dextrose Monohydrate 10% InjectionEndocrinology/Metabolism, Gastroenterology, Other, Pediatric | Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-74) | Current | Available | 1 Mar 202215 Sept 2026 |
| Dextrose Monohydrate 10% InjectionEndocrinology/Metabolism, Gastroenterology, Other, Pediatric | Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-75) | Current | Available | 1 Mar 202215 Sept 2026 |
| Dextrose Monohydrate 10% InjectionEndocrinology/Metabolism, Gastroenterology, Other, Pediatric | Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-76) | Current | Available | 1 Mar 202215 Sept 2026 |
| Dextrose Monohydrate 5% InjectionEndocrinology/Metabolism, Gastroenterology, Other, Pediatric | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-458-30) | Current | Available | 14 Feb 202215 Sept 2026 |
| Dextrose Monohydrate 5% InjectionEndocrinology/Metabolism, Gastroenterology, Other, Pediatric | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-464-50) | Current | Available | 14 Feb 202215 Sept 2026 |
| Dextrose Monohydrate 5% InjectionEndocrinology/Metabolism, Gastroenterology, Other, Pediatric | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-462-10) | Current | Available | 14 Feb 202215 Sept 2026 |
| Dextrose Monohydrate 5% InjectionEndocrinology/Metabolism, Gastroenterology, Other, Pediatric | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-456-60) | Current | Available | 14 Feb 202215 Sept 2026 |
| Dextrose Monohydrate 5% InjectionEndocrinology/Metabolism, Gastroenterology, Other, Pediatric | Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-460-20) | Current | Available | 14 Feb 202215 Sept 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57) | Current | Available | 14 Oct 201615 Sept 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37) | Current | Available | 14 Oct 201615 Sept 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37) | Current | Available | 14 Oct 201615 Sept 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17) | Current | Available | 14 Oct 201615 Sept 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27) | Current | Unavailable | 14 Oct 201615 Sept 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17) | Current | Unavailable | 14 Oct 201615 Sept 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27) | Current | Available | 14 Oct 201615 Sept 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17) | Current | Available | 14 Oct 201615 Sept 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57) | Current | Unavailable | 14 Oct 201615 Sept 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17) | Current | Available | 14 Oct 201615 Sept 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27) | Current | Available | 14 Oct 201615 Sept 2026 |
| Epinephrine Bitartrate, Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57) | Current | Unavailable | 14 Oct 201615 Sept 2026 |
| Fentanyl Citrate InjectionAnalgesia/Addiction, Pediatric | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01) | Current | Available | 1 Jan 201215 Sept 2026 |
| Fentanyl Citrate InjectionAnalgesia/Addiction, Pediatric | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02) | Current | Unavailable | 1 Jan 201215 Sept 2026 |
| Fentanyl Citrate InjectionAnalgesia/Addiction, Pediatric | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05) | Current | Available | 1 Jan 201215 Sept 2026 |
| Fentanyl Citrate InjectionAnalgesia/Addiction, Pediatric | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20) | Current | Available | 1 Jan 201215 Sept 2026 |
| Fentanyl Citrate InjectionAnalgesia/Addiction, Pediatric | Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11) | Current | Available | 1 Jan 201215 Sept 2026 |
| Fentanyl Citrate InjectionAnalgesia/Addiction, Pediatric | Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50) | Current | Available | 1 Jan 201215 Sept 2026 |
| Furosemide InjectionCardiovascular | Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-04) | Current | Available | 7 Apr 202015 Sept 2026 |
| Furosemide InjectionCardiovascular | Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-02) | Current | Available | 7 Apr 202015 Sept 2026 |
| Furosemide InjectionCardiovascular | Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-10) | Current | Available | 7 Apr 202015 Sept 2026 |
| Heparin Sodium InjectionHematology | Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10) | Current | Available | 14 Nov 201715 Sept 2026 |
| Heparin Sodium InjectionHematology | Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77) | Current | Unavailable | 14 Nov 201715 Sept 2026 |
| Hydromorphone Hydrochloride InjectionAnalgesia/Addiction | Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25) | Current | Unavailable | 31 Oct 201715 Sept 2026 |
| Hydromorphone Hydrochloride InjectionAnalgesia/Addiction | Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11) | Current | Unavailable | 31 Oct 201715 Sept 2026 |
| Hydromorphone Hydrochloride InjectionAnalgesia/Addiction | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10) | Current | Available | 31 Oct 201715 Sept 2026 |
| Hydromorphone Hydrochloride InjectionAnalgesia/Addiction | Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11) | Current | Unavailable | 1 Nov 201715 Sept 2026 |
| Hydromorphone Hydrochloride InjectionAnalgesia/Addiction | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50) | Current | Available | 31 Oct 201715 Sept 2026 |
| Hydromorphone Hydrochloride InjectionAnalgesia/Addiction | Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25) | Current | Unavailable | 31 Oct 201715 Sept 2026 |
| Hydromorphone Hydrochloride InjectionAnalgesia/Addiction | Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10) | Current | Available | 1 Nov 201715 Sept 2026 |
| Hydromorphone Hydrochloride InjectionAnalgesia/Addiction | Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06) | Current | Unavailable | 31 Oct 201715 Sept 2026 |
| Hydromorphone Hydrochloride InjectionAnalgesia/Addiction | Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11) | Current | Unavailable | 1 Nov 201715 Sept 2026 |
| Hydromorphone Hydrochloride InjectionAnalgesia/Addiction | Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15) | Current | Available | 31 Oct 201715 Sept 2026 |
| Ifosfamide InjectionOncology, Pediatric | Ifosfamide, Injection, 1 g/1 (NDC 63323-142-10) | Current | Limited Availability | 12 Jun 202615 Sept 2026 |
| Ketorolac Tromethamine InjectionAnalgesia/Addiction | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01) | Current | Available | 23 Mar 201815 Sept 2026 |
| Ketorolac Tromethamine InjectionAnalgesia/Addiction | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02) | Current | Unavailable | 23 Mar 201815 Sept 2026 |
| Ketorolac Tromethamine InjectionAnalgesia/Addiction | Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20) | Current | Unavailable | 23 Mar 201815 Sept 2026 |
| Ketorolac Tromethamine InjectionAnalgesia/Addiction | Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10) | Current | Unavailable | 23 Mar 201815 Sept 2026 |
| Ketorolac Tromethamine InjectionAnalgesia/Addiction | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01) | Current | Unavailable | 23 Mar 201815 Sept 2026 |
| Ketorolac Tromethamine InjectionAnalgesia/Addiction | Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10) | Current | Unavailable | 23 Mar 201815 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57) | Current | Unavailable | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37) | Current | Available | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57) | Current | Available | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05) | Current | Unavailable | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57) | Current | Available | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97) | Current | Unavailable | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27) | Current | Available | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27) | Current | Available | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97) | Current | Unavailable | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27) | Current | Unavailable | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91) | Current | Unavailable | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07) | Current | Unavailable | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02) | Current | Available | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31) | Current | Unavailable | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57) | Current | Available | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02) | Current | Available | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10) | Current | Unavailable | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17) | Current | Available | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27) | Current | Unavailable | 22 Feb 201215 Sept 2026 |
| Lidocaine Hydrochloride InjectionAnesthesia, Pediatric | Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57) | Current | Available | 22 Feb 201215 Sept 2026 |
| Lorazepam InjectionNeurology | Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02) | Current | Unavailable | 3 May 201815 Sept 2026 |
| Methotrexate Sodium InjectionRheumatology, Oncology | Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50) | Current | Available | 13 Mar 202315 Sept 2026 |
| Methotrexate Sodium InjectionRheumatology, Oncology | Methotrexate Sodium, Injection, 25 mg/1 mL (NDC 63323-123-10) | Current | Available | 13 Mar 202315 Sept 2026 |
| Midazolam Hydrochloride InjectionAnesthesia, Neurology | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25) | Current | Available | 2 Apr 202015 Sept 2026 |
| Midazolam Hydrochloride InjectionAnesthesia, Neurology | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25) | Current | Unavailable | 2 Apr 202015 Sept 2026 |
| Midazolam Hydrochloride InjectionAnesthesia, Neurology | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10) | Current | Unavailable | 2 Apr 202015 Sept 2026 |
| Midazolam Hydrochloride InjectionAnesthesia, Neurology | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10) | Current | Unavailable | 2 Apr 202015 Sept 2026 |
| Midazolam Hydrochloride InjectionAnesthesia, Neurology | Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20) | Current | Unavailable | 2 Apr 202015 Sept 2026 |
| Midazolam Hydrochloride InjectionAnesthesia, Neurology | Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12) | Current | Available | 2 Apr 202015 Sept 2026 |
| Midazolam Hydrochloride InjectionAnesthesia, Neurology | Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02) | Current | Available | 2 Apr 202015 Sept 2026 |
| Morphine Sulfate InjectionAnalgesia/Addiction | Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01) | Current | Unavailable | 31 Oct 201715 Sept 2026 |
| Morphine Sulfate InjectionAnalgesia/Addiction | Morphine Sulfate, Injection, 5 mg/1 mL (NDC 63323-455-01) | Current | Unavailable | 31 Oct 201715 Sept 2026 |
| Morphine Sulfate InjectionAnalgesia/Addiction | Morphine Sulfate, Injection, 4 mg/1 mL (NDC 76045-005-11) | Current | Unavailable | 31 Oct 201715 Sept 2026 |
| Morphine Sulfate InjectionAnalgesia/Addiction | Morphine Sulfate, Injection, 2 mg/1 mL (NDC 76045-004-11) | Current | Unavailable | 31 Oct 201715 Sept 2026 |
| Morphine Sulfate InjectionAnalgesia/Addiction | Morphine Sulfate, Injection, 4 mg/1 mL (NDC 63323-454-01) | Current | Unavailable | 31 Oct 201715 Sept 2026 |
| Morphine Sulfate InjectionAnalgesia/Addiction | Morphine Sulfate, Injection, 10 mg/1 mL (NDC 63323-451-01) | Current | Available | 31 Oct 201715 Sept 2026 |
| Propranolol Hydrochloride InjectionCardiovascular | Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01) | Current | Available | 31 Oct 202315 Sept 2026 |
| Remifentanil Hydrochloride InjectionAnalgesia/Addiction | Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03) | Current | Available | 28 Jun 202215 Sept 2026 |
| Remifentanil Hydrochloride InjectionAnalgesia/Addiction | Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-725-10) | Current | Available | 28 Jun 202215 Sept 2026 |
| Remifentanil Hydrochloride InjectionAnalgesia/Addiction | Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-724-05) | Current | Unavailable | 28 Jun 202215 Sept 2026 |
| Rifampin InjectionAnti-Infective | Rifampin, Injection, 600 mg (NDC 63323-351-20) | Current | Limited Availability | 17 Feb 202115 Sept 2026 |
| Rocuronium Bromide InjectionAnesthesia | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10) | Current | Available | 15 Feb 202315 Sept 2026 |
| Rocuronium Bromide InjectionAnesthesia | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05) | Current | Unavailable | 15 Feb 202315 Sept 2026 |
| Rocuronium Bromide InjectionAnesthesia | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05) | Current | Available | 15 Feb 202315 Sept 2026 |
| Rocuronium Bromide InjectionAnesthesia | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05) | Current | Unavailable | 15 Feb 202315 Sept 2026 |
| Rocuronium Bromide InjectionAnesthesia | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10) | Current | Available | 15 Feb 202315 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63) | Current | Unavailable | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20) | Current | Unavailable | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63) | Current | Available | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21) | Current | Available | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20) | Current | Unavailable | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31) | Current | Unavailable | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20) | Current | Unavailable | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11) | Current | Available | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10) | Current | Unavailable | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21) | Current | Available | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64) | Current | Available | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13) | Current | Available | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20) | Current | Available | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23) | Current | Available | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23) | Current | Available | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61) | Current | Unavailable | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65) | Current | Available | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00) | Current | Available | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35) | Current | Available | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10) | Current | Unavailable | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10) | Current | Available | 23 Mar 201815 Sept 2026 |
| Ropivacaine Hydrochloride InjectionAnesthesia | Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20) | Current | Unavailable | 23 Mar 201815 Sept 2026 |
| Sodium Acetate InjectionTotal Parenteral Nutrition | Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00) | Current | Available | 23 Mar 201615 Sept 2026 |
| Sodium Bicarbonate InjectionEndocrinology/Metabolism, Gastroenterology, Pediatric | Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 63323-083-05) | Current | Available | 24 Jul 201715 Sept 2026 |
| Sodium Bicarbonate InjectionEndocrinology/Metabolism, Gastroenterology, Pediatric | Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 63323-089-50) | Current | Available | 24 Jul 201715 Sept 2026 |
| Sterile Water InjectionOther | Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-20) | Current | Available | 23 Nov 202115 Sept 2026 |
| Sterile Water InjectionOther | Sterile Water, Injection, 1000 mL/1000 mL (NDC 63323-178-76) | Current | Available | 23 Nov 202115 Sept 2026 |
| Sterile Water InjectionOther | Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-10) | Current | Unavailable | 23 Nov 202115 Sept 2026 |
| Sterile Water InjectionOther | Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-50) | Current | Available | 23 Nov 202115 Sept 2026 |
| Valproate Sodium InjectionNeurology | Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05) | Current | Available | 30 Dec 202015 Sept 2026 |
| Atropine Sulfate InjectionAnesthesia, Neurology, Pediatric | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20) | Current | Available | 1 Jan 20121 Sept 2026 |
| Ifosfamide InjectionOncology, Pediatric | Ifosfamide, Injection, 1 g (NDC 63323-142-10) | Current | Limited Availability | 12 Jun 20261 Sept 2026 |
| Bumetanide InjectionCardiovascular | Bumetanide, Injection, .25 mg/1 mL (NDC 65219-570-04) | Resolved | - | 31 Jan 201830 Sept 2026 |
| Bumetanide InjectionCardiovascular | Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10) | Resolved | - | 31 Jan 201830 Sept 2026 |
| Arsenic Trioxide InjectionOncology | Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 63323-637-10) | To Be Discontinued | - | 21 Sept 202621 Sept 2026 |
| Melphalan Hydrochloride InjectionOncology | Melphalan Hydrochloride, Injection, Kit (NDC 63323-760-20) | To Be Discontinued | - | 16 Sept 202616 Sept 2026 |
| Potassium Chloride, Sodium Chloride, Calcium Chloride, and Magnesium Chloride Injection, SolutionCardiovascular | Cardioplegic Solution, Injection, Solution, 17.6 mg/100 mL; 325.3 mg/100 mL; 119.3 mg/100 mL; 643 mg/100 mL (NDC 65219-258-10) | To Be Discontinued | - | 31 Aug 202631 Aug 2026 |
| Fulvestrant InjectionOncology | Fulvestrant, Injection, 250 mg per 5mL (NDC 63323-715-05) | To Be Discontinued | - | 14 Aug 202614 Aug 2026 |
| Glycopyrrolate InjectionAnesthesia | Glycopyrrolate, Injection, .2 mg/1 mL (NDC 63323-578-01) | To Be Discontinued | - | 30 Jul 202630 Jul 2026 |
| Glycopyrrolate InjectionAnesthesia | Glycopyrrolate, Injection, 0.2 mg per 1 mL (NDC 65219-801-01) | To Be Discontinued | - | 30 Jul 202630 Jul 2026 |
| Glycopyrrolate InjectionAnesthesia | Glycopyrrolate, Injection, 1 mg per 5 mL (NDC 63323-578-05) | To Be Discontinued | - | 30 Jul 202630 Jul 2026 |
| Glycopyrrolate InjectionAnesthesia | Glycopyrrolate, Injection, 0.4 mg per 2 mL (NDC 63323-578-02) | To Be Discontinued | - | 30 Jul 202630 Jul 2026 |
| Succinylcholine Chloride InjectionAnesthesia | Succinylcholine Chloride, Injection, 20 mg/1 mL (NDC 63323-943-10) | To Be Discontinued | - | 23 Jul 202623 Jul 2026 |
| Icatibant Acetate InjectionHematology | Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-86) | To Be Discontinued | - | 7 May 20267 May 2026 |
| Icatibant Acetate InjectionHematology | Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-93) | To Be Discontinued | - | 7 May 20267 May 2026 |
| Fosaprepitant Dimeglumine InjectionGastroenterology | Fosaprepitant Dimeglumine, Injection, 150 mg/5 mL (NDC 63323-972-10) | To Be Discontinued | - | 8 Apr 20268 Apr 2026 |
| Plerixafor InjectionHematology | Plerixafor, Injection, 24 mg per 1.2 mL (20 mg per mL) (NDC 65219-284-12) | To Be Discontinued | - | 13 Mar 202613 Mar 2026 |
| Oxaliplatin InjectionOncology | Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-10) | To Be Discontinued | - | 25 Feb 202625 Feb 2026 |
| Oxaliplatin InjectionOncology | Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-20) | To Be Discontinued | - | 25 Feb 202625 Feb 2026 |
| Cefepime Hydrochloride InjectionAnti-Infective | Cefepime Hydrochloride, Injection, 2 g (NDC 63323-340-20) | To Be Discontinued | - | 10 Feb 202610 Feb 2026 |
| Cefepime Hydrochloride InjectionAnti-Infective | Cefepime Hydrochloride, Injection, 1 g (NDC 63323-326-20) | To Be Discontinued | - | 10 Feb 202610 Feb 2026 |
| Benztropine Mesylate InjectionNeurology | Benztropine Mesylate, Injection, 1 mg/1 mL (NDC 63323-970-02) | To Be Discontinued | - | 27 Jan 202627 Jan 2026 |
| Piperacillin and Tazobactam InjectionAnti-Infective | Piperacillin and Tazobactam, Injection, 2.25 g vial (NDC 65219-434-20) | To Be Discontinued | - | 20 Jan 202620 Jan 2026 |
| Caspofungin Acetate InjectionAnti-Infective | Caspofungin Acetate, Injection, 7 mg/1 mL (NDC 63323-358-10) | To Be Discontinued | - | 12 Jan 202612 Jan 2026 |
| Neostigmine Methylsulfate InjectionAnalgesia/Addiction | Neostigmine Methylsulfate, Injection, .5 mg/1 mL (NDC 63323-413-10) | To Be Discontinued | - | 12 Jan 202612 Jan 2026 |
| Haloperidol Decanoate InjectionPsychiatry | Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-01) | To Be Discontinued | - | 9 Jan 20269 Jan 2026 |
| Haloperidol Decanoate InjectionPsychiatry | Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-05) | To Be Discontinued | - | 9 Jan 20269 Jan 2026 |
| Moxifloxacin InjectionAnti-Infective | Moxifloxacin, Injection, 400mg per 250mL (NDC 63323-850-74) | To Be Discontinued | - | 29 Oct 202529 Oct 2025 |
Catalogue
Drug listings by form and route
561561 active NDC listings: 560 human prescription drug, 1 bulk ingredient. By marketing category: ANDA 399, NDA 123, BLA 22, NDA AUTHORIZED GENERIC 11, UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE 3.
| Dosage form | NDCs |
|---|---|
| injection, solution | 320 |
| injection | 78 |
| injection, powder, lyophilized, for solution | 71 |
| injection, powder, for solution | 29 |
| injection, solution, concentrate | 17 |
| kit | 12 |
| solution | 10 |
| injection, emulsion | 9 |
| emulsion | 8 |
| powder, for solution | 5 |
| inhalant | 1 |
| powder | 1 |
| Route | NDCs |
|---|---|
| intravenous | 441 |
| intramuscular | 142 |
| subcutaneous | 80 |
| infiltration | 35 |
| perineural | 33 |
| epidural | 26 |
| intracaudal | 16 |
| oral | 10 |
| respiratory (inhalation) | 7 |
| irrigation | 6 |
| intra-arterial | 4 |
| intrathecal | 4 |
| intra-articular | 2 |
| intralesional | 2 |
| intrapleural | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| fresenius kabi usa, llc | 537 |
| fresenius kabi usa, llc | 11 |
| fresenius kabi, usa llc | 6 |
| fresenius kabi usa llc | 2 |
| fresenius kabi, llc | 2 |
| fresenius kabi ab | 1 |
| fresenius kabi usa, llc | 1 |
| fresenius kabi, usa, llc | 1 |
Exclusivity
Patents and exclusivities
73| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 7857802 | NAROPINropivacaine hydrochloride | product | Nov 2026 |
| 8741959 | ACETAMINOPHENacetaminophen | product | Apr 2030 |
| 9731082 | DILAUDID, DILAUDID-HPhydromorphone hydrochloride | product | Apr 2032 |
| 9168238 | LEVOTHYROXINE SODIUMlevothyroxine sodium | product | Aug 2032 |
| 9168239 | LEVOTHYROXINE SODIUMlevothyroxine sodium | product | Aug 2032 |
| 9006289 | LEVOTHYROXINE SODIUMlevothyroxine sodium | product | Oct 2032 |
| 8962572 | BORTEZOMIBbortezomib | product | Nov 2032 |
| 9636407 | CASPOFUNGIN ACETATEcaspofungin acetate | product | Dec 2032 |
| 10188663 | FULVESTRANTfulvestrant | product | Feb 2034 |
| 9833459 | FULVESTRANTfulvestrant | product | Feb 2034 |
| 9072781 | MORPHINE SULFATEmorphine sulfate | product | Mar 2034 |
| 9192608 | MORPHINE SULFATEmorphine sulfate | use | Mar 2034 |
| 9248229 | DILAUDID, DILAUDID-HP, MORPHINE SULFATEhydromorphone hydrochloride; morphine sulfate | product | Mar 2034 |
| 9271990 | FULVESTRANTfulvestrant | product | May 2034 |
| 12390398 | KABIVEN IN PLASTIC CONTAINER, PERIKABIVEN IN PLASTIC CONTAINERamino acids; calcium chloride; dextrose; magnesium sulfate; potassium chloride; sodium acetate; sodium glycerophosphate; soybean oil | product | May 2036 |
| 10398669 | LEVOTHYROXINE SODIUMlevothyroxine sodium | product | Dec 2036 |
| 11135190 | LEVOTHYROXINE SODIUMlevothyroxine sodium | product | Dec 2036 |
| 12636270 | LEVOTHYROXINE SODIUMlevothyroxine sodium | product | Dec 2036 |
| 9782376 | LEVOTHYROXINE SODIUMlevothyroxine sodium | product | Dec 2036 |
| 10130646 | CALCIUM GLUCONATE IN SODIUM CHLORIDEcalcium gluconate | product | Jul 2037 |
| 11813291 | POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDEpotassium phosphate, dibasic; potassium phosphate, monobasic | product | Oct 2041 |
| 11925661 | POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDEpotassium phosphate, dibasic; potassium phosphate, monobasic | product | Oct 2041 |
| 12539283 | EPINEPHRINEepinephrine | product | Jan 2045 |
Catalogue
Marketed products
561Showing 150 of 561.
| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Acetaminophen | ACETAMINOPHEN | injection, intravenous | 63323-434NDA |
| Acetylcysteine | ACETYLCYSTEINE | solution, oral, respiratory (inhalation) | 63323-690ANDA |
| Acetylcysteine | ACETYLCYSTEINE | solution, oral, respiratory (inhalation) | 63323-691ANDA |
| Acetylcysteine | ACETYLCYSTEINE | solution, oral, respiratory (inhalation) | 63323-692ANDA |
| Acetylcysteine | ACETYLCYSTEINE | solution, oral, respiratory (inhalation) | 63323-693ANDA |
| Acetylcysteine | ACETYLCYSTEINE | solution, oral, respiratory (inhalation) | 63323-694ANDA |
| Acetylcysteine | ACETYLCYSTEINE | solution, oral, respiratory (inhalation) | 63323-695ANDA |
| Acetylcysteine | Acetylcysteine | injection, solution, intravenous | 63323-963ANDA |
| Acyclovir | Acyclovir | injection, solution, intravenous | 63323-325ANDA |
| Adalimumab-aacf | adalimumab | kit, subcutaneous | 65219-612BLA |
| Adalimumab-aacf | adalimumab | kit, subcutaneous | 65219-620BLA |
| Adenosine | ADENOSINE | injection, solution, intravenous | 63323-651ANDA |
| Allopurinol | Allopurinol | injection, powder, lyophilized, for solution, intravenous | 65219-380ANDA |
| Amikacin Sulfate | Amikacin Sulfate | injection, solution, intramuscular, intravenous | 63323-815ANDA |
| Amiodarone Hydrochloride | AMIODARONE HYDROCHLORIDE | injection, solution, intravenous | 63323-616ANDA |
| Amiodarone Hydrochloride | AMIODARONE HYDROCHLORIDE | injection, solution, intravenous | 65219-643ANDA |
| Amiodarone Hydrochloride | AMIODARONE HYDROCHLORIDE | injection, solution, intravenous | 65219-645ANDA |
| Ampicillin | ampicillin sodium | injection, powder, for solution, intramuscular, intravenous | 65219-014ANDA |
| Ampicillin | ampicillin sodium | injection, powder, for solution, intramuscular, intravenous | 65219-016ANDA |
| Ampicillin | ampicillin sodium | injection, powder, for solution, intramuscular, intravenous | 65219-018ANDA |
| Ampicillin | ampicillin sodium | injection, powder, for solution, intramuscular, intravenous | 65219-020ANDA |
| Argatroban | Argatroban | injection, intravenous | 65219-429ANDA |
| Arsenic Trioxide | Arsenic Trioxide | injection, solution, intravenous | 63323-637ANDA |
| Ascorbic Acid | Ascorbic Acid | injection, intravenous | 65219-027ANDA |
| Atropine Sulfate | Atropine Sulfate | injection, solution, endotracheal, intramedullary, intramuscular, intravenous, subcutaneous | 63323-580NDA |
| Azacitidine | Azacitidine | injection, powder, lyophilized, for solution, intravenous, subcutaneous | 63323-771ANDA |
| Azithromycin | AZITHROMYCIN MONOHYDRATE | injection, powder, lyophilized, for solution, intravenous | 63323-398ANDA |
| Aztreonam | AZTREONAM | injection, powder, lyophilized, for solution, intramuscular, intravenous | 63323-401ANDA |
| Aztreonam | AZTREONAM | injection, powder, lyophilized, for solution, intramuscular, intravenous | 63323-402ANDA |
| BENZTROPINE MESYLATE | BENZTROPINE MESYLATE | injection, solution, intramuscular, intravenous | 63323-970ANDA |
| BOMYNTRA | Denosumab | injection, subcutaneous | 65219-670BLA |
| BOMYNTRA | Denosumab | injection, subcutaneous | 65219-672BLA |
| Bacteriostatic Sodium Chloride | SODIUM CHLORIDE | injection, intramuscular, intravenous, subcutaneous | 63323-924ANDA |
| Bivalirudin | Bivalirudin | injection, powder, lyophilized, for solution, intravenous | 63323-562ANDA |
| Bleomycin | BLEOMYCIN SULFATE | injection, powder, lyophilized, for solution, intramuscular, intrapleural, intravenous, subcutaneous | 63323-136ANDA |
| Bleomycin | BLEOMYCIN SULFATE | injection, powder, lyophilized, for solution, intramuscular, intrapleural, intravenous, subcutaneous | 63323-137ANDA |
| Bortezomib | Bortezomib | injection, powder, lyophilized, for solution, intravenous, subcutaneous | 63323-821ANDA |
| Bumetanide | Bumetanide | injection, intramuscular, intravenous | 65219-570ANDA |
| Bumetanide | Bumetanide | injection, intramuscular, intravenous | 65219-572ANDA |
| CARBOPROST TROMETHAMINE | carboprost tromethamine | injection, solution, intramuscular | 65219-579ANDA |
| CEFAZOLIN | CEFAZOLIN SODIUM | powder, for solution, intramuscular, intravenous | 63323-236ANDA |
| CEFAZOLIN | CEFAZOLIN SODIUM | powder, for solution, intramuscular, intravenous | 63323-237ANDA |
| CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | injection, intramuscular | 65219-128ANDA |
| CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | injection, intramuscular | 65219-130ANDA |
| CLOFARABINE | clofarabine | injection, intravenous | 63323-572ANDA |
| CONEXXENCE | Denosumab | injection, subcutaneous | 65219-668BLA |
| Caffeine Citrate | CAFFEINE CITRATE | solution, oral | 63323-406ANDA |
| Caffeine Citrate | CAFFEINE CITRATE | injection, solution, intravenous | 63323-407ANDA |
| Calcitonin Salmon | Calcitonin Salmon | injection, solution, intramuscular, subcutaneous | 63323-865ANDA |
| Calcium Gluconate | Calcium Gluconate | injection, solution, intravenous | 63323-360NDA |
| Calcium Gluconate | Calcium Gluconate | injection, solution, intravenous | 65219-162NDA |
| Calcium Gluconate | Calcium Gluconate | injection, solution, intravenous | 65219-164NDA |
| Calcium Gluconate | Calcium Gluconate | injection, solution, intravenous | 65219-630NDA |
| Carboplatin | CARBOPLATIN | injection, solution, intravenous | 63323-172ANDA |
| Cardioplegic Solution | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, and MAGNESIUM CHLORIDE | injection, solution, intra-arterial | 65219-258ANDA |
| Caspofungin Acetate | Caspofungin Acetate | injection, powder, lyophilized, for solution, intravenous | 63323-356NDA |
| Caspofungin Acetate | Caspofungin Acetate | injection, powder, lyophilized, for solution, intravenous | 63323-358NDA |
| Cefazolin | Cefazolin Sodium | powder, for solution, intravenous | 63323-238ANDA |
| Cefepime | Cefepime | injection, powder, for solution, intramuscular, intravenous | 63323-326ANDA |
| Cefepime | Cefepime | injection, powder, for solution, intravenous | 63323-340ANDA |
| Cefotetan | CEFOTETAN DISODIUM | injection, powder, for solution, intramuscular, intravenous | 63323-385ANDA |
| Cefotetan | CEFOTETAN DISODIUM | injection, powder, for solution, intramuscular, intravenous | 63323-386ANDA |
| Cefoxitin | Cefoxitin Sodium | powder, for solution, intravenous | 63323-341ANDA |
| Cefoxitin | Cefoxitin Sodium | powder, for solution, intravenous | 63323-342ANDA |
| Ceftriaxone | Ceftriaxone | injection, powder, for solution, intramuscular, intravenous | 63323-346ANDA |
| Chloramphenicol Sodium Succinate | CHLORAMPHENICOL SODIUM SUCCINATE | injection, powder, lyophilized, for solution, intravenous | 63323-011ANDA |
| Chlorothiazide | CHLOROTHIAZIDE SODIUM | injection, powder, lyophilized, for solution, intravenous | 63323-658ANDA |
| Chorionic Gonadotropin | Chorionic Gonadotropin | kit | 63323-030BLA |
| Cisatracurium | CISATRACURIUM BESYLATE | injection, solution, intravenous | 63323-416ANDA |
| Cisatracurium | CISATRACURIUM BESYLATE | injection, solution, intravenous | 63323-417ANDA |
| Cisatracurium | CISATRACURIUM BESYLATE | injection, solution, intravenous | 63323-418ANDA |
| Cisplatin | CISPLATIN | injection, solution, intravenous | 63323-103ANDA |
| Cladribine | CLADRIBINE | injection, intravenous | 63323-140ANDA |
| Colistimethate | COLISTIMETHATE SODIUM | injection, powder, lyophilized, for solution, intramuscular, intravenous | 63323-393ANDA |
| Cyanocobalamin | CYANOCOBALAMIN | injection, solution, intramuscular, subcutaneous | 63323-044ANDA |
| Cyclophosphamide | cyclophosphamide | injection, powder, for solution, intravenous, oral | 65219-131ANDA |
| Cyclophosphamide | cyclophosphamide | injection, powder, for solution, intravenous, oral | 65219-133ANDA |
| Cyclophosphamide | cyclophosphamide | injection, powder, for solution, intravenous, oral | 65219-135ANDA |
| Cytarabine | CYTARABINE | injection, solution, intrathecal, intravenous, subcutaneous | 63323-120ANDA |
| DALBAVANCIN HYDROCHLORIDE | DALBAVANCIN HYDROCHLORIDE | injection, powder, for solution, intravenous | 65219-120ANDA |
| DEXTROSE AND SODIUM CHLORIDE | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE | injection, solution, intravenous | 63323-874ANDA |
| Dacarbazine | DACARBAZINE | injection, powder, for solution, intravenous | 63323-127ANDA |
| Dacarbazine | DACARBAZINE | injection, powder, for solution, intravenous | 63323-128ANDA |
| Daptomycin | Daptomycin | injection, powder, lyophilized, for solution, intravenous | 63323-371ANDA |
| Deferoxamine | DEFEROXAMINE MESYLATE | injection, powder, lyophilized, for solution, intramuscular, intravenous, subcutaneous | 63323-597ANDA |
| Deferoxamine | DEFEROXAMINE MESYLATE | injection, powder, lyophilized, for solution, intramuscular, intravenous, subcutaneous | 63323-599ANDA |
| Desmopressin Acetate | Desmopressin Acetate | injection, solution, intravenous, subcutaneous | 65219-293ANDA |
| Desmopressin Acetate | Desmopressin Acetate | injection, solution, intravenous, subcutaneous | 65219-295ANDA |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | injection, solution, intramuscular, intravenous | 63323-165ANDA |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | injection, solution, intramuscular, intravenous | 63323-506ANDA |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | injection, solution, intramuscular, intravenous | 63323-516ANDA |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | injection, solution, intra-articular, intralesional, intramuscular, intravenous, soft tissue | 76045-106ANDA |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | injection, emulsion, intramuscular, intravenous | 76045-109ANDA |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | injection, solution, intra-articular, intralesional, intramuscular, intravenous, soft tissue | 76045-210ANDA |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | injection, emulsion, intramuscular, intravenous | 76045-212ANDA |
| Dexmedetomidine Hydrochloride | dexmedetomidine hydrochloride | injection, solution, intravenous | 63323-421ANDA |
| Dexmedetomidine Hydrochloride | dexmedetomidine hydrochloride | injection, solution, intravenous | 65219-642ANDA |
| Dextrose | Dextrose Monohydrate | injection, solution, intravenous | 63323-624ANDA |
| Dextrose | Dextrose Monohydrate | injection, solution, intravenous | 63323-824ANDA |
| Dextrose | Dextrose Monohydrate | injection, solution, intravenous | 65219-234ANDA |
| Dextrose | Dextrose Monohydrate | injection, solution, intravenous | 65219-236ANDA |
| Dextrose | Dextrose Monohydrate | injection, solution, intravenous | 65219-238ANDA |
| Dextrose | Dextrose Monohydrate | injection, solution, intravenous | 65219-240ANDA |
| Dextrose | Dextrose Monohydrate | injection, solution, intravenous | 65219-456ANDA |
| Dextrose | Dextrose Monohydrate | injection, solution, intravenous | 65219-458ANDA |
| Dextrose | Dextrose Monohydrate | injection, solution, intravenous | 65219-460ANDA |
| Dextrose | Dextrose Monohydrate | injection, solution, intravenous | 65219-462ANDA |
| Dextrose | Dextrose Monohydrate | injection, solution, intravenous | 65219-464ANDA |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE and SODIUM CHLORIDE | injection, solution, intravenous | 63323-867ANDA |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE and SODIUM CHLORIDE | injection, solution, intravenous | 63323-869ANDA |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE and SODIUM CHLORIDE | injection, solution, intravenous | 63323-870ANDA |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE and SODIUM CHLORIDE | injection, solution, intravenous | 63323-873ANDA |
| Diazepam | DIAZEPAM | injection, solution, intramuscular, intravenous | 76045-204ANDA |
| Dicyclomine Hydrochloride | Dicyclomine Hydrochloride | injection, solution, intramuscular | 63323-842ANDA |
| Dilaudid | Hydromorphone hydrochloride | injection, solution, intramuscular, intravenous, subcutaneous | 76045-009NDA |
| Dilaudid | Hydromorphone hydrochloride | injection, solution, intramuscular, intravenous, subcutaneous | 76045-010NDA |
| Dilaudid | Hydromorphone hydrochloride | injection, solution, intramuscular, intravenous, subcutaneous | 76045-121NDA |
| Dimenhydrinate | Dimenhydrinate | injection, solution, intramuscular, intravenous | 63323-366ANDA |
| Diphenhydramine | DIPHENHYDRAMINE HYDROCHLORIDE | injection, solution, intramuscular, intravenous | 63323-664ANDA |
| Diphenhydramine | DIPHENHYDRAMINE HYDROCHLORIDE | injection, solution, intramuscular, intravenous | 65219-820ANDA |
| Diphenhydramine Hydrochloride | Diphenhydramine Hydrochloride | injection, solution, intramuscular, intravenous | 76045-102ANDA |
| Diphenhydramine Hydrochloride | Diphenhydramine Hydrochloride | injection, solution, intramuscular, intravenous | 76045-235ANDA |
| Diprivan | PROPOFOL | injection, emulsion, intravenous | 63323-269NDA |
| Diprivan | PROPOFOL | injection, emulsion, intravenous | 65219-800NDA |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | injection, solution, intravenous | 63323-101ANDA |
| Doxorubicin Hydrochloride | DOXORUBICIN HYDROCHLORIDE | injection, solution, intravenous | 63323-883ANDA |
| Doxy 100 | DOXYCYCLINE | injection, powder, lyophilized, for solution, intravenous | 63323-130ANDA |
| EPINEPHRINE | EPINEPHRINE | injection, solution, concentrate, intramuscular, intraocular, intravenous, subcutaneous | 63323-696ANDA |
| EPINEPHRINE | EPINEPHRINE | injection, solution, concentrate, intramuscular, intravenous, subcutaneous | 63323-698NDA |
| Enoxaparin Sodium | enoxaparin sodium | injection, subcutaneous | 63323-531NDA AUTHORIZED GENERIC |
| Enoxaparin Sodium | enoxaparin sodium | injection, subcutaneous | 63323-533NDA AUTHORIZED GENERIC |
| Enoxaparin Sodium | enoxaparin sodium | injection, subcutaneous | 63323-535NDA AUTHORIZED GENERIC |
| Enoxaparin Sodium | enoxaparin sodium | injection, subcutaneous | 63323-537NDA AUTHORIZED GENERIC |
| Enoxaparin Sodium | enoxaparin sodium | injection, intravenous, subcutaneous | 63323-539NDA AUTHORIZED GENERIC |
| Enoxaparin Sodium | Enoxaparin Sodium | injection, subcutaneous | 63323-559ANDA |
| Enoxaparin Sodium | Enoxaparin Sodium | injection, subcutaneous | 63323-564ANDA |
| Enoxaparin Sodium | Enoxaparin Sodium | injection, subcutaneous | 63323-566ANDA |
| Enoxaparin Sodium | Enoxaparin Sodium | injection, subcutaneous | 63323-584ANDA |
| Enoxaparin Sodium | Enoxaparin Sodium | injection, subcutaneous | 63323-586ANDA |
| Enoxaparin Sodium | Enoxaparin Sodium | injection, subcutaneous | 63323-589ANDA |
| Enoxaparin Sodium | enoxaparin sodium | injection, subcutaneous | 63323-605NDA AUTHORIZED GENERIC |
| Enoxaparin Sodium | enoxaparin sodium | injection, subcutaneous | 63323-607NDA AUTHORIZED GENERIC |
| Enoxaparin Sodium | enoxaparin sodium | injection, subcutaneous | 63323-609NDA AUTHORIZED GENERIC |
| Enoxaparin Sodium | Enoxaparin Sodium | injection, subcutaneous | 63323-655ANDA |
| Ephedrine Sulfate | Ephedrine Sulfate | injection, intravenous | 65219-257ANDA |
| Ertapenem | Ertapenem Sodium | injection, powder, lyophilized, for solution, intramuscular, intravenous | 63323-823ANDA |
| Esmolol Hydrochloride | ESMOLOL HYDROCHLORIDE | injection, solution, intravenous | 63323-652ANDA |
| Esmolol Hydrochloride | ESMOLOL HYDROCHLORIDE | injection, solution, intravenous | 63323-661ANDA |
| Etomidate | Etomidate | injection, solution, intravenous | 65219-445ANDA |
| Etomidate | Etomidate | injection, solution, intravenous | 65219-447ANDA |
Neighbours
Registered in the same town
6- Eurofins BioPharma Product Testing Sweden ABUppsala, SWE · 2 sites
- Merck & Co., Inc.Wilson, NC
- Novavax, Inc.Uppsala, SWE
- Microbac Laboratories, Inc.Wilson, NC
- Precision Stability Storage, LLCWilson, NC
- Knoa Pharma LLCWilson, NC
Compare
Comparable companies in United States
- Spectrum Pharmaceuticals, Inc.6 sites · 240 NDC
- Ecolab Inc.6 sites · 105 NDC
- Eisai Inc.6 sites · 51 NDC
- Elanco US Inc.6 sites · 46 NDC
- BASF Corporation6 sites · 24 NDC
- Fresenius Medical Care Renal Therapies Group, LLC6 sites · 7 NDC
- Holston Gases, Inc.6 sites · 4 NDC
- General Distributing Co.6 sites · 3 NDC
- Reliant Holdings, Ltd6 sites · 1 NDC
- TransOx, Inc.6 sites · 1 NDC
Enquiry
Common questions
- Is Fresenius Kabi USA, LLC FDA approved?
- Fresenius Kabi USA, LLC holds 6 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Fresenius Kabi USA, LLC's drugs manufactured?
- At registered sites in Sweden, the United States. The FDA register lists Kungsangen; Uppsala; Grand Island, NY; Melrose Park, IL; Wilson, NC. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture.
- What drugs does Fresenius Kabi USA, LLC make?
- 561 products are listed under Fresenius Kabi USA, LLC in the openFDA NDC Directory, most often as injection, solution; injection; injection, powder, lyophilized, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
- Are any Fresenius Kabi USA, LLC products in shortage?
- 159 presentations are currently listed in the FDA drug shortage database under Fresenius Kabi USA, LLC, covering Azacitidine Injection, Bupivacaine Hydrochloride Injection, Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection and 27 other drugs.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.